Study Suggests More Testing is Needed Before Testosterone Therapy Treatment is Prescribed, Reports Baron and Budd
Team of Researchers Recommends Blood Tests Be Used in Conjunction with Physical Exams
DALLAS (PRWEB) April 26, 2014
The national law firm of Baron and Budd reports that a study conducted by a panel of physicians recommends doctors not rely on blood tests alone when determining whether a patient suffers from low testosterone. The study, spearheaded by the American Urological Association (AUA), included data from more than 10,000 patients. It will be published in the May issue of Urology and was published online February 17, 2014(http://www.goldjournal.net/article/S0090-4295(13)01611-7/abstract).
According to the AUA study, unreliable blood test results are a major issue when diagnosing low testosterone. Testosterone (T) levels tested in different labs from the same blood sample can vary by as much as 30 percent. Therefore, it is very important that doctors perform a physical exam when diagnosing low testosterone and use T levels from blood tests as a secondary guideline.
The researchers recommend health care providers insist that laboratories follow standardized guidelines issued by the Centers for Disease Control for testing T levels. They also recommend that testosterone blood tests be standardized in a way that is comparable to the hemoglobin A1C test, which analyzes blood glucose levels and helps physicians diagnose diabetes.
Testosterone therapy products have been linked to several different health issues in men, including heart attacks and strokes. The U.S. Food and Drug Administration (FDA) released an announcement on Jan. 31, 2014 stating that it is performing an investigation regarding the risk of health problems in men taking the products (http://www.fda.gov/drugs/drugsafety/ucm383904.htm).
“We applaud any recommendations that can potentially lead to fewer people being adversely affected by products meant to treat low testosterone,” said Stephen Blackburn, attorney at Baron and Budd. “The health risks associated with these products can be truly devastating.”
Please contact the national law firm of Baron and Budd if you or a loved one has suffered a heart attack, stroke or blot clot after taking Testosterone, know as “Low T,” therapy products such as AndroGel, Androderm, Axiron and Testim. Call us at 866-472-9108 or visit our website for more information at http://baronandbudd.com/areas-of-practice/pharmaceuticals/testosterone-therapy/.
ABOUT BARON AND BUDD
The law firm of Baron and Budd, with offices in Dallas, Baton Rouge, Austin and Los Angeles, is a nationally recognized law firm with over 35 years of “Protecting What’s Right” for people, communities and businesses harmed by negligence. Baron & Budd’s size and resources enable the firm to take on large and complex cases. The firm represents individuals, governmental and business entities in areas as diverse as water contamination, Gulf oil spill, Qui Tam, California Proposition 65 violations, unsafe drugs and medical devices, Chinese drywall, deceptive advertising, consumer financial fraud, securities fraud and asbestos cancers such as mesothelioma.
For the original version on PRWeb visit: http://www.prweb.com/releases/2014/04/prweb11790810.htm